Lucile Garidou
Affiliations: | 2005-2009 | National Institutes of Health-NINDS |
Google:
"Lucile Garidou"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Dorian B. McGavern | post-doc | 2005-2009 | National Institutes of Health-NINDS |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pomié C, Blasco-Baque V, Klopp P, et al. (2016) Triggering the adaptive immune system with commensal gut bacteria protects against insulin resistance and dysglycemia. Molecular Metabolism. 5: 392-403 |
| Blasco-Baque V, Garidou L, Pomié C, et al. (2016) Periodontitis induced by Porphyromonas gingivalis drives periodontal microbiota dysbiosis and insulin resistance via an impaired adaptive immune response. Gut |
| Pomié C, Garidou L, Burcelin R. (2016) Intestinal RORrt-generated Th17 cells control type 2 diabetes: A first antidiabetic target identified from the host to microbiota crosstalk Inflammation and Cell Signaling. 3 |
| Garidou L, Pomié C, Klopp P, et al. (2015) The Gut Microbiota Regulates Intestinal CD4 T Cells Expressing RORγt and Controls Metabolic Disease. Cell Metabolism. 22: 100-12 |
| Denou E, Lolmède K, Garidou L, et al. (2015) Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance. Embo Molecular Medicine. 7: 259-74 |
| Luche E, Cousin B, Garidou L, et al. (2013) Metabolic endotoxemia directly increases the proliferation of adipocyte precursors at the onset of metabolic diseases through a CD14-dependent mechanism. Molecular Metabolism. 2: 281-91 |
| Burcelin R, Serino M, Chabo C, et al. (2013) Metagenome and metabolism: the tissue microbiota hypothesis. Diabetes, Obesity & Metabolism. 15: 61-70 |
| Garidou L, Heydari S, Gossa S, et al. (2012) Therapeutic blockade of transforming growth factor beta fails to promote clearance of a persistent viral infection. Journal of Virology. 86: 7060-71 |
| Burcelin R, Garidou L, Pomié C. (2012) Immuno-microbiota cross and talk: the new paradigm of metabolic diseases. Seminars in Immunology. 24: 67-74 |
| Truong P, Heydari S, Garidou L, et al. (2009) Persistent viral infection elevates central nervous system MHC class I through chronic production of interferons. Journal of Immunology (Baltimore, Md. : 1950). 183: 3895-905 |